Healthcare

Request for TOC Request for Sample
BUY NOW

Global Atrial Fibrillation Surgery Market – Industry Trends and Forecast to 2028

Healthcare | Upcoming Report | May 2021 | Global | 350 Pages | No of Tables: 220 | No of Figures: 60

Report Description

Global Atrial Fibrillation Surgery Market, By Product (Catheter Ablation, Surgical Ablation), Procedure (Catheter Ablation, Surgical Ablation/Maze procedure, AV Node Ablation), End User (Hospitals, Ambulatory Surgical Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights of Atrial Fibrillation Surgery Market

The atrial fibrillation surgery market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 5,847.47 million by 2028 and will grow at a CAGR of 12.87% in the above mentioned forecast period.

Atrial fibrillation is a method used to treat irregular heart rhythm which begins in the upper chambers of the heart (atria). It is a kind of cardiac ablation that works by scarring or destroying the tissue in the heart to interrupt the false electrical signals that cause arrhythmia.

The rise in the volume of patients suffering from heart related disorders is amongst the important factor expected to intensify the growth and demand of atrial fibrillation surgery market. In addition, the rise in obesity, hypertension and  heart diseases among the majority of people are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the rise in the preferences towards catheter ablation for cardiac arrhythmia treatment and rise in incidences of CVD and atrial fibrillation are also likely to enhance the growth of the market. Furthermore, the reduced mortality rate and positive outcomes of the atrial fibrillation device are also one of the significant factors expected to fuel the growth of the atrial fibrillation surgery market.

The rapid advancement in technology, rise in the number of atrial fibrillation surgical and catheter ablation procedures and increase in the applications from emerging economiesare anticipated to offer significant growth opportunities for the market in the forecast period of 2021 to 2028.

However, the dearth of skilled and trained personnel and unfavorable preferences to pharmaceutical drugs over AF treatment devices are expected to curb the growth of the atrial fibrillation surgery market, whereas the high recurrence and complication rates  can challenge the growth of the atrial fibrillation surgery market.

This atrial fibrillation surgery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the atrial fibrillation surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Atrial Fibrillation Surgery Market Scope and Market Size

The atrial fibrillation surgery market is segmented on the basis of product, procedure and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product, the atrial fibrillation surgery market is segmented into catheter ablation and surgical ablation.
  • The procedure segment of atrial fibrillation surgery market is segmented into catheter ablation, surgical ablation/maze procedure and AV node ablation.
  • On the basis of end user, the atrial fibrillation surgery market is segmented into hospitals, ambulatory surgical centers and others.

Atrial Fibrillation Surgery Market Country Level Analysis

The atrial fibrillation surgery market is analyzed and market size insights and trends are provided by country, product, procedure and end user as referenced above.

The countries covered in the atrial fibrillation surgery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the atrial fibrillation surgery market owing to the rise in the prevalence of atrial fibrillation and increase in awareness among the population. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the regulatory policies in emerging countries are more adaptive and business-friendly, owing to the presence of less strict regulations and data requirements. 

The country section of the atrial fibrillation surgery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The atrial fibrillation surgery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for atrial fibrillation surgery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the atrial fibrillation surgery market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Atrial Fibrillation Surgery Market Share Analysis

The atrial fibrillation surgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to atrial fibrillation surgery market.

The major players covered in the atrial fibrillation surgery market report are Abbott, Johnson & Johnson Services, Inc., MicroPort Scientific Corporation., Boston Scientific Corporation, St. Jude Medical, Inc., Medtronic, Boehringer Ingelheim International GmbH., BIOTRONIK SE & Co. KG, Koninklijke Philips N.V., Siemens AG, AtriCure, Inc., sanofi-aventis U.S. LLC, Biosense Webster, Inc, OSYPKA AG, CardioFocus., Bristol-Myers Squibb Company, Vanguard AG, GENERAL ELECTRIC COMPANY, Pfizer Inc.,  and Biomerics among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Table of Content

Please fill in the below form for detailed Table of Content

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19